How low can we go: Achieving postoperative day 1 discharge after deep inferior epigastric perforator, a safe and feasible goal.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2025 Vol.102() p. 152-158

Nguyen AT, Hu VJ, Clark RC, Gosman AA, Reid CM

관련 도메인

Abstract

[BACKGROUND] Although rare reports describe discharge to be possible within 48 hours for patients undergoing autologous breast reconstruction, average length of stay remains around 3 days. This study aimed to demonstrate that patients can be safely discharged within 1 day after deep inferior epigastric perforator (DIEP) flap breast reconstruction.

[METHODS] A retrospective review was performed of patients who underwent free flap breast reconstruction by a single surgeon from November 2021 to May 2024. Demographics, operative details, opioid ingestion, length of stay, and postoperative complications were reviewed to assess safety of discharge in 24 hours.

[RESULTS] One hundred sixty-four DIEP flaps were performed on 119 patients. Average length of stay was 1.5 days (SD 0.7 days), with 67 (56.3%) patients discharged on postoperative day 1 (POD1) and 52 (43.7%) discharged after POD1. Of those discharged on POD1, 13 (19.4%) went home in <24 hours. Comparing patients discharged on POD1 to those discharged after POD1, there were statistically significant differences in reconstruction laterality (76.1% vs 44.2% unilateral, p<0.001), operative time (341.0 vs 439.1 minutes, p<0.001), and opioid ingestion on POD1 (4.2 IV morphine milligram equivalents [MME] vs 11.3 MME, p<0.001). Common complications included abdominal wound dehiscence (10.1%), abdominal seroma (5.0%), breast wound dehiscence (4.9%), and breast mastectomy flap necrosis (3.0%). Seventy-six (63.9%) patients had no complications. Overall success rate of flap reconstruction was 100%.

[CONCLUSION] Collaboration among surgery, anesthesia, and dedicated nursing teams allow 23-hour observation or outpatient DIEP reconstruction to be safe and feasible. By attaining equivalency with implant-based reconstruction, access to flap reconstruction can be extended to more patients.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 5
시술 flap 피판재건술 dict 4
합병증 wound dehiscence 상처열개 dict 2
시술 free flap 피판재건술 dict 1
합병증 seroma 장액종 dict 1
합병증 flap necrosis 괴사 dict 1
합병증 flap breast scispacy 1
합병증 abdominal wound scispacy 1
합병증 abdominal seroma scispacy 1
합병증 23-hour scispacy 1
약물 morphine C0026549
morphine
scispacy 1
약물 equivalents [MME] scispacy 1
약물 MME C0066662
1,2,3,4,9,9-hexachloro-1,4,4a,5,8,8a-hexahydro-6- methyl-6,7-epoxy-1,4-methanonaphthalene
scispacy 1
약물 [BACKGROUND] scispacy 1
약물 opioid scispacy 1
약물 [RESULTS] One hundred sixty-four DIEP flaps scispacy 1
질환 DIEP → deep inferior epigastric perforator scispacy 1
질환 abdominal wound dehiscence scispacy 1
질환 abdominal seroma scispacy 1
질환 breast wound dehiscence scispacy 1
질환 necrosis C0027540
Necrosis
scispacy 1
질환 breast wound scispacy 1
질환 breast mastectomy flap scispacy 1
기타 patients scispacy 1
기타 POD1 → postoperative day 1 scispacy 1
기타 POD1 (4.2 IV morphine milligram equivalents [MME scispacy 1
기타 MME scispacy 1
기타 DIEP → deep inferior epigastric perforator scispacy 1
기타 implant-based scispacy 1

MeSH Terms

Humans; Mammaplasty; Female; Retrospective Studies; Perforator Flap; Middle Aged; Patient Discharge; Length of Stay; Epigastric Arteries; Adult; Postoperative Complications; Feasibility Studies; Time Factors; Aged; Operative Time

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문